HEADER TRANSFERASE/PROTEIN BINDING 23-AUG-14 2MTN TITLE SOLUTION STRUCTURE OF MLL-IBD COMPLEX COMPND MOL_ID: 1; COMPND 2 MOLECULE: HISTONE-LYSINE N-METHYLTRANSFERASE 2A, PC4 AND SFRS1- COMPND 3 INTERACTING PROTEIN FUSION; COMPND 4 CHAIN: A; COMPND 5 SYNONYM: LYSINE N-METHYLTRANSFERASE 2A, ALL-1, CXXC-TYPE ZINC FINGER COMPND 6 PROTEIN 7, MYELOID/LYMPHOID OR MIXED-LINEAGE LEUKEMIA, COMPND 7 MYELOID/LYMPHOID OR MIXED-LINEAGE LEUKEMIA PROTEIN 1, TRITHORAX-LIKE COMPND 8 PROTEIN, ZINC FINGER PROTEIN HRX, MLL CLEAVAGE PRODUCT N320, N- COMPND 9 TERMINAL CLEAVAGE PRODUCT OF 320 KDA, P320, MLL CLEAVAGE PRODUCT COMPND 10 C180, C-TERMINAL CLEAVAGE PRODUCT OF 180 KDA, P180, CLL-ASSOCIATED COMPND 11 ANTIGEN KW-7, DENSE FINE SPECKLES 70 KDA PROTEIN, DFS 70, LENS COMPND 12 EPITHELIUM-DERIVED GROWTH FACTOR, TRANSCRIPTIONAL COACTIVATOR COMPND 13 P75/P52; COMPND 14 EC: 2.1.1.43; COMPND 15 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ALL1, CXXC7, DFS70, HRX, HTRX, KMT2A, LEDGF, MLL, MLL1, PSIP1, SOURCE 6 PSIP2, TRX1, DFS70, LEDGF, PSIP1, PSIP2; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 9 EXPRESSION_SYSTEM_VECTOR: PET32A KEYWDS PROTEIN-PROTEIN COMPLEX, TRANSFERASE-PROTEIN BINDING COMPLEX EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR T.CIERPICKI,J.POLLOCK,M.MURAI REVDAT 3 01-MAY-24 2MTN 1 REMARK SEQADV REVDAT 2 22-APR-15 2MTN 1 JRNL REVDAT 1 03-DEC-14 2MTN 0 JRNL AUTH M.J.MURAI,J.POLLOCK,S.HE,H.MIAO,T.PUROHIT,A.YOKOM,J.L.HESS, JRNL AUTH 2 A.G.MUNTEAN,J.GREMBECKA,T.CIERPICKI JRNL TITL THE SAME SITE ON THE INTEGRASE-BINDING DOMAIN OF LENS JRNL TITL 2 EPITHELIUM-DERIVED GROWTH FACTOR IS A THERAPEUTIC TARGET FOR JRNL TITL 3 MLL LEUKEMIA AND HIV. JRNL REF BLOOD V. 124 3730 2014 JRNL REFN ISSN 0006-4971 JRNL PMID 25305204 JRNL DOI 10.1182/BLOOD-2014-01-550079 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CYANA 2.1, CYANA 2.1 REMARK 3 AUTHORS : GUNTERT, MUMENTHALER AND WUTHRICH (CYANA), REMARK 3 GUNTERT, MUMENTHALER AND WUTHRICH (CYANA) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2MTN COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 28-AUG-14. REMARK 100 THE DEPOSITION ID IS D_1000104030. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 6.5 REMARK 210 IONIC STRENGTH : 0.05 REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 50 MM POTASSIUM PHOSPHATE, 50 MM REMARK 210 SODIUM CHLORIDE, 90% H2O/10% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-15N HSQC; 3D 1H-13C NOESY REMARK 210 ALIPHATIC; 3D 1H-15N NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NMRPIPE, SPARKY REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 465 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 MODELS 1-20 REMARK 465 RES C SSSEQI REMARK 465 GLY A 105 REMARK 465 PRO A 106 REMARK 465 ALA A 107 REMARK 465 MET A 108 REMARK 465 ALA A 109 REMARK 465 PRO A 110 REMARK 465 GLY A 111 REMARK 465 PHE A 112 REMARK 465 ASP A 113 REMARK 465 ALA A 114 REMARK 465 ALA A 115 REMARK 465 LEU A 116 REMARK 465 GLN A 117 REMARK 465 VAL A 118 REMARK 465 SER A 119 REMARK 465 ALA A 120 REMARK 465 ALA A 121 REMARK 465 GLU A 329 REMARK 465 GLU A 330 REMARK 465 VAL A 331 REMARK 465 ARG A 332 REMARK 465 VAL A 333 REMARK 465 ARG A 334 REMARK 465 GLY A 335 REMARK 465 SER A 336 REMARK 465 VAL A 337 REMARK 465 LYS A 338 REMARK 465 LYS A 339 REMARK 465 VAL A 340 REMARK 465 GLU A 341 REMARK 465 LYS A 342 REMARK 465 LYS A 343 REMARK 465 ARG A 344 REMARK 465 THR A 437 REMARK 465 GLN A 438 REMARK 465 VAL A 439 REMARK 465 LEU A 440 REMARK 465 ASN A 441 REMARK 465 LYS A 442 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 PHE A 151 87.24 -151.77 REMARK 500 1 SER A 153 58.13 -96.65 REMARK 500 1 LYS A 364 -169.40 -114.82 REMARK 500 1 LEU A 368 103.10 -51.52 REMARK 500 1 VAL A 429 -73.53 -51.45 REMARK 500 1 SER A 434 131.67 -172.39 REMARK 500 2 PHE A 133 -55.04 -125.50 REMARK 500 2 PHE A 148 106.49 -162.63 REMARK 500 2 SER A 347 175.35 -59.18 REMARK 500 2 ASP A 366 -74.96 -70.64 REMARK 500 2 ASN A 367 73.36 -106.13 REMARK 500 2 LEU A 368 88.21 -67.21 REMARK 500 3 SER A 409 129.21 -173.33 REMARK 500 4 GLN A 147 175.04 -55.03 REMARK 500 4 SER A 153 -74.36 -115.29 REMARK 500 4 LEU A 363 40.07 -94.66 REMARK 500 4 LEU A 368 105.74 -59.93 REMARK 500 4 SER A 434 146.29 -173.96 REMARK 500 5 GLU A 146 41.91 39.41 REMARK 500 5 PHE A 148 106.07 -162.58 REMARK 500 5 THR A 346 33.28 -95.30 REMARK 500 5 LEU A 363 39.49 -94.83 REMARK 500 5 ASP A 366 -74.30 -68.61 REMARK 500 6 ASP A 145 31.38 -97.73 REMARK 500 6 GLU A 146 54.29 -113.26 REMARK 500 6 GLN A 147 -174.74 -61.07 REMARK 500 6 PHE A 148 108.20 -162.76 REMARK 500 6 LEU A 363 32.26 -95.79 REMARK 500 6 SER A 409 133.29 -170.58 REMARK 500 6 ASP A 433 44.13 -102.09 REMARK 500 7 SER A 153 -73.78 -138.77 REMARK 500 7 ASP A 433 128.45 -171.58 REMARK 500 8 ASP A 145 43.20 -104.87 REMARK 500 8 LEU A 363 40.01 -94.72 REMARK 500 8 ASN A 367 85.62 176.12 REMARK 500 8 SER A 434 -40.62 -131.44 REMARK 500 9 SER A 153 -51.83 -126.11 REMARK 500 9 LEU A 363 40.10 -106.28 REMARK 500 9 LEU A 368 103.64 -51.53 REMARK 500 10 ASP A 145 44.02 -102.22 REMARK 500 10 PHE A 148 105.64 -162.72 REMARK 500 10 ASN A 367 66.02 63.47 REMARK 500 10 HIS A 393 27.28 -143.21 REMARK 500 11 PHE A 148 106.32 -162.89 REMARK 500 11 LEU A 363 41.07 -93.81 REMARK 500 11 ASP A 366 -75.29 -86.83 REMARK 500 11 ASN A 367 49.52 -89.17 REMARK 500 11 LEU A 368 101.37 -55.39 REMARK 500 11 SER A 434 145.94 -172.51 REMARK 500 11 VAL A 435 47.03 -95.62 REMARK 500 REMARK 500 THIS ENTRY HAS 105 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 25171 RELATED DB: BMRB DBREF 2MTN A 110 334 UNP Q03164 KMT2A_HUMAN 110 160 DBREF 2MTN A 337 442 UNP O75475 PSIP1_HUMAN 337 442 SEQADV 2MTN GLY A 105 UNP Q03164 EXPRESSION TAG SEQADV 2MTN PRO A 106 UNP Q03164 EXPRESSION TAG SEQADV 2MTN ALA A 107 UNP Q03164 EXPRESSION TAG SEQADV 2MTN MET A 108 UNP Q03164 EXPRESSION TAG SEQADV 2MTN ALA A 109 UNP Q03164 EXPRESSION TAG SEQADV 2MTN GLY A 335 UNP Q03164 LINKER SEQADV 2MTN SER A 336 UNP Q03164 LINKER SEQRES 1 A 164 GLY PRO ALA MET ALA PRO GLY PHE ASP ALA ALA LEU GLN SEQRES 2 A 164 VAL SER ALA ALA ILE GLY THR ASN LEU ARG ARG PHE ARG SEQRES 3 A 164 ALA VAL PHE GLY GLU SER GLY GLY GLY GLY GLY SER GLY SEQRES 4 A 164 GLU ASP GLU GLN PHE LEU GLY PHE GLY SER ASP GLU GLU SEQRES 5 A 164 VAL ARG VAL ARG GLY SER VAL LYS LYS VAL GLU LYS LYS SEQRES 6 A 164 ARG GLU THR SER MET ASP SER ARG LEU GLN ARG ILE HIS SEQRES 7 A 164 ALA GLU ILE LYS ASN SER LEU LYS ILE ASP ASN LEU ASP SEQRES 8 A 164 VAL ASN ARG CYS ILE GLU ALA LEU ASP GLU LEU ALA SER SEQRES 9 A 164 LEU GLN VAL THR MET GLN GLN ALA GLN LYS HIS THR GLU SEQRES 10 A 164 MET ILE THR THR LEU LYS LYS ILE ARG ARG PHE LYS VAL SEQRES 11 A 164 SER GLN VAL ILE MET GLU LYS SER THR MET LEU TYR ASN SEQRES 12 A 164 LYS PHE LYS ASN MET PHE LEU VAL GLY GLU GLY ASP SER SEQRES 13 A 164 VAL ILE THR GLN VAL LEU ASN LYS HELIX 1 1 GLY A 123 VAL A 132 1 10 HELIX 2 2 MET A 348 LEU A 363 1 16 HELIX 3 3 ASP A 369 LEU A 383 1 15 HELIX 4 4 THR A 386 GLN A 391 1 6 HELIX 5 5 HIS A 393 ARG A 404 1 12 HELIX 6 6 SER A 409 GLY A 430 1 22 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1